Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
OSBORNE DAVID W
Chief Technical Officer at Arcutis Biotherapeutics. Filing since 29 Sep 2020.
CIK 0001252999
Company
Date
Role
Action
Shares
Amount
Of holding
ARQT
Arcutis Biotherapeutics, Inc.
6 Mar 2023
Chief Technical Officer
Sold, plan not stated
690
$10.53K
0.3%
ARQT
Arcutis Biotherapeutics, Inc.
2 Mar 2023
Chief Technical Officer
Sold, plan not stated
1,213
$19.20K
0.5%
ARQT
Arcutis Biotherapeutics, Inc.
28 Feb 2023
Chief Technical Officer
Sold, plan not stated
792
$12.80K
0.3%
ARQT
Arcutis Biotherapeutics, Inc.
8 Jul 2022
Chief Technical Officer
Sold, plan not stated
2,197
$55.84K
0.8%
ARQT
Arcutis Biotherapeutics, Inc.
21 Apr 2022
Chief Technical Officer
Sold, plan not stated
2,197
$44.87K
0.8%
ARQT
Arcutis Biotherapeutics, Inc.
7 Mar 2022
Chief Technical Officer
Sold, plan not stated
28
$460.46
0.0%
ARQT
Arcutis Biotherapeutics, Inc.
4 Mar 2022
Chief Technical Officer
Sold, plan not stated
828
$13.96K
0.3%
ARQT
Arcutis Biotherapeutics, Inc.
1 Mar 2022
Chief Technical Officer
Sold, plan not stated
775
$13.76K
0.3%
ARQT
Arcutis Biotherapeutics, Inc.
1 Mar 2021
Chief Technical Officer
Sold, plan not stated
780
$26.97K
0.3%
ARQT
Arcutis Biotherapeutics, Inc.
14 Dec 2020
Chief Technical Officer
Sold, plan not stated
15,000
$450.00K
5.6%
ARQT
Arcutis Biotherapeutics, Inc.
29 Sep 2020
Chief Technical Officer
Sold, plan not stated
15,000
$450.00K
5.4%
11 decisions on file.
